Biopharmaceuticals
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
Aim & Scope
This section is dedicated to research on the therapeutic, diagnostic, prognostic and immunoprophylactic developments of important biological macromolecules built from amino acids, sugars, nucleic acids, comprising small basic units of which they are composed, and mimetics produced by chemical synthesis. Contributions focusing on biopharmaceutical applications of more complex entities, such as phages, viruses, exosomes and stem cells, among others, are also welcome. Also reports on structure and molecular interactions determinant for biopharmaceuticals bioactivity or pharmaceutical applications, e.g. by computational and NMR studies are also accepted. Download Section Flyer
Keywords
- Peptides
- Proteins
- RNA
- DNA
- Nucleic Acids
- Aptamers
- Carbohydrates
- Glycans
- Polysaccharides
- Macromolecules
- Chemical Synthesis
- Ribonucleoproteins
- Antibodies
- Phages
- Viruses
- Therapeutic Tools
- Peptidomimetics
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Innovations in Integrin-Targeted Drug Delivery: From Peptide Conjugates to Dual-Action Therapeutics (Deadline: 31 August 2026)
- Protein Silencing in Pharmaceutical Applications (Deadline: 31 August 2026)
- Targeting Enzymes in Drug Design and Discovery (Deadline: 25 September 2026)
- Targeting the Proteostasis Network: From Fundamental Mechanisms to Therapeutic Innovation (Deadline: 30 September 2026)
- Potential Therapeutic Roles of RNA and Protein Molecules in Cardiovascular Diseases (Deadline: 30 September 2026)
- Pleiotropic Agents and Their Therapeutic Potential in Gastroenterology, Angiology, and Musculoskeletal Disorders (Deadline: 30 September 2026)
- Next-Generation Approaches for Cartilage Regeneration (Deadline: 25 October 2026)
- New Structural, Biophysical and Computational Perspectives on the Use of Proteins in Drug Design and Discovery (Deadline: 31 October 2026)
- Peptide-Based Therapeutics: Targeting Amylin, Calcitonin, and Related Receptors (Deadline: 31 October 2026)
- DNA Repair Targeted Therapy: New Advances in Cancer Treatment (Deadline: 31 October 2026)
- Genome Editing and Sequencing Technology-Driven RNA Regulation Research in Cancer (Deadline: 25 November 2026)
- Emerging Biomarkers in Autoimmune Diseases: From Pharmacodynamic Insights to Therapeutic Translation (Deadline: 25 November 2026)
- Extracellular Vesicles and Bioinspired Nanovesicles as Next-Generation Drug-Delivery Systems (Deadline: 25 November 2026)
- Exosome and Biotherapeutic Strategies for Dermatological and Oncological Skin Complications (Deadline: 30 November 2026)
- Biosimilars in Oncology: Applications in Pharmaceutics and Pharmaceuticals (Deadline: 30 November 2026)
- Advances in Solid-Phase Peptide and Oligonucleotide Synthesis: Methods, Mechanisms, and Therapeutic Applications (Deadline: 30 November 2026)
- Therapeutic Applications of Micro-RNA in Cancer Management—2nd Edition (Deadline: 25 December 2026)
- Targeting the NLRP3: From Novel Inhibitor Design to Clinic Trials and Therapeutic Applications (Deadline: 31 December 2026)
- Immunogenicity of Biologics: From Risk Assessment to Mitigation Strategies (Deadline: 31 December 2026)
- HIV and Viral Hepatitis Prevention, Treatment and Coinfection, 2nd Edition (Deadline: 25 January 2027)
- Gut Microbiota and Metabolites: Novel Strategies for Intestinal Inflammation Therapy (Deadline: 31 January 2027)
- Advances in Regulatory Mechanisms and Therapeutic Potential of Non-Coding RNAs in Neurodegenerative Diseases (Deadline: 31 January 2027)
- Advances in Non-Coding RNAs as Prognostic Biomarkers, Therapeutic Targets, and Regulatory Mechanisms in Cancer (Deadline: 31 January 2027)
- Cancer Stem Cells as Novel Therapeutic Targets (Deadline: 31 January 2027)
- Analytical Technologies in Biopharmaceutical Quality Control (Deadline: 31 January 2027)
- Advances in GPCR Drug Discovery (Deadline: 22 February 2027)
- Pharmaceutical Blood Products (Deadline: 28 February 2027)
Topical Collection
Following topical collection within this section is currently open for submissions:
